210 results on '"Xu, Jian-Ming"'
Search Results
2. SIMULTANEOUS INVERSION OF THE SOURCE TERM AND INITIAL VALUE OF THE TIME FRACTIONAL DIFFUSION EQUATION
3. Cluster-Based Two-Level Mesh Routing Protocol for Wireless Sensor Network
4. The Quasi-Boundary Regularization Method for Recovering the Initial Value in a Nonlinear Time–Space Fractional Diffusion Equation
5. Supplementary Table 5 from PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer
6. Supplementary Table 2 from PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer
7. Supplementary Table 4 from PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer
8. Supplementary Table 6 and Table 7 from PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer
9. Supplementary Table 1 from PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer
10. Supplementary Table 3 from PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer
11. Regularization methods for identifying the initial value of time fractional pseudo-parabolic equation
12. A tuff interlayer in deep potash-bearing salt rocks and its implication for potash mineralization in the Simao Basin, southwestern China
13. Sintilimab in Patients with Previously Treated Metastatic Neuroendocrine Neoplasms
14. A tuff interlayer in deep potash-bearing salt rocks and its implication for potash mineralization in the Simao Basin, southwestern China
15. Negative air ion exposure ameliorates depression-like behaviors induced by chronic mild stress in mice
16. Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer
17. Chinese Consensus Report on Family-BasedHelicobacter pyloriInfection Control and Management (2021 Edition)
18. Treatment Patterns and Outcomes in Chinese Patients with Gastric Cancer by HER2 Status: A Noninterventional Registry Study (EVIDENCE)
19. Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms
20. Topology reconstruction based fault identification for uncertain multi-agent systems with application to multi-axis motion control system
21. Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 trial (ORIENT-2)
22. Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis
23. Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours
24. Post‑radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma
25. Document-Specific Statistical Machine Translation for Improving Human Translation Productivity
26. Fault-tolerant Control for Linear System Under Sensor Saturation Constraint
27. Tislelizumab plus chemotherapy as first-line treatment for unresectable, locally advanced recurrent/metastatic esophageal squamous cell carcinoma.
28. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial
29. Phase I study of fluzoparib, a PARP1 Inhibitor in combination with apatinib and paclitaxel in patients (pts) with advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma.
30. Phase I study of KN035, the first subcutaneously administered, novel fusion anti-PD-L1 antibody in patients with advanced solid tumors in China.
31. S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.
32. A randomized, placebo-controlled, phase III trial-in-progress to evaluate the efficacy and safety of tislelizumab plus chemotherapy as first-line treatment for unresectable, locally advanced recurrent/metastatic esophageal squamous cell carcinoma (ESCC).
33. Association of co-occuring mutations in exosomal DNA and clinical outcomes of patients with metastatic colorectal cancer.
34. Preparation of carbon nanotube/epoxy composite films with high tensile strength and electrical conductivity by impregnation under pressure
35. Computer-assisted diagnosis of early esophageal squamous cell carcinoma using narrow-band imaging magnifying endoscopy
36. A multicenter, single arm phase II trial of a small molecule immune-modulator icaritin: Safety, overall survival, immune dynamics, and PD-L1 expression in advanced hepatocellular carcinoma.
37. Final overall survival (OS) analysis of first-line (1L) FOLFOX-4 ± cetuximab (cet) in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) in the phase 3 TAILOR trial.
38. Development of NKG2D chimeric antigen receptor-T cells as targeted therapy of liver cancer.
39. Circulating tumor DNA clone analysis to predict disease progression/indicates trastuzumab-resistant mechanism in advanced gastric cancer.
40. Quality-adjusted time without symptoms or toxicity (Q-TWiST) of patients with metastatic colorectal cancer (mCRC) treated with fruquintinib in the randomized phase III FRESCO trial.
41. Postradiation ctDNA status as a prognostic factor in locally advanced esophageal squamous cell carcinoma.
42. A first-in-human phase 1a trial of sintilimab (IBI308), a monoclonal antibody targeting programmed death-1 (PD-1), in Chinese patients with advanced solid tumors.
43. Trastuzumab plus docetaxel and capecitabine for first-line treatment of Her2-positive advanced gastric cancer: A phase II, multi-center, open-label, single-arm study.
44. Dynamic change of PD-L1 expression on circulating tumor cells in advanced gastrointestinal tumor patients undergoing PD-1 blockade therapy.
45. Anti-programmed death-1 antibody SHR-1210 (S) combined with apatinib (A) for advanced hepatocellular carcinoma (HCC), gastric cancer (GC) or esophagogastric junction (EGJ) cancer refractory to standard therapy: A phase 1 trial.
46. Magnetostratigraphy and 230 Th dating of a drill core from the southeastern Qaidam Basin: Salt lake evolution and tectonic implications
47. Melatonin Ameliorates Liver Fibrosis Induced by Carbon Tetrachloride in Rats via Inhibiting TGF-β1/Smad Signaling Pathway
48. What may cause fetus loss from acute pancreatitis in pregnancy
49. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
50. Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.